Altimmune's Pemvidutide received Breakthrough Therapy Designation from the FDA.
2 reports, 1 independent
Updated Aug 12
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Altimmune's Pemvidutide received Breakthrough Therapy Designation from the FDA.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Altimmune, Inc.
American biopharmaceutical company